Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
Medtronic Endovascular
Study ID
NCT07335341
Status
Recruiting
Apply to this trial

Conditions

  • Acute DVT of Lower Extremity
  • Acute Limb Ischemia
  • Arterial Embolism and Thrombosis
  • Chronic DVT of Lower Extremity
  • DVT
  • Deep Vein Thrombosis Leg
  • LE ALI
  • Lower Extremity Acute Limb Ischemia
  • Peripheral Arterial Disease
  • Thrombus in the Peripheral Venous Vasculature
  • Venous Embolism of Lower Extremities (Diagnosis)

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Liberant Thrombectomy System — DEVICE
    The Liberant thrombectomy system is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems

Study Details

The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems

Key Dates

Start date
Feb 24, 2026
Status verified
Jun 2026
Primary completion
Oct 31, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

Rate of Device related Serious Adverse Event at Index procedure [ Time Frame: Index Procedure ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
MedStar HealthWashington D.C.District of Columbia003329
Manasa Gudipally
Naples Comprehensive HealthNaplesFlorida34108
Manasa Gudipally

Find similar trials in Washington D.C., DC

By research site
MedStar Health· Washington D.C., DCNaples Comprehensive Health· Naples, FL

Related Studies